Is A or BDSX more undervalued in 2026?

CirclFi compares Agilent Technologies, Inc. (A) and Biodesix, Inc. (BDSX) using 13 institutional-grade valuation models. A has a Quality of Company score of 9.5/10 while BDSX scores 6.0/10.

Which is a better buy — A or BDSX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do A and BDSX valuations compare?

A at $135.38 and BDSX at $15.99 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

A vs BDSX Valuation Comparison 2026 — Intrinsic Value Analysis

A

Diagnostics & Research

Agilent Technologies, Inc.

Quality

9.5

out of 10

Value Trap

SAFE

Price

$135.38

Last close

Models

13/13

Active

BDSX

Diagnostics & Research

Biodesix, Inc.

Quality

6.0

out of 10

Value Trap

LOW

Price

$15.99

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	A Fair Value	A Upside	BDSX Fair Value	BDSX Upside
Bayesian DCF	Intrinsic	$72.69	-46.3%	$1.93	-88.0%
Earnings Power Value	Intrinsic	$32.33	-76.1%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.53	-97.4%	$0.47	-96.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for A vs BDSX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

A vs BDSX — Which Stock Is More Undervalued?

A scores higher with a 9.5/10 quality rating vs BDSX's 6.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Agilent Technologies, Inc. (A) and Biodesix, Inc. (BDSX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

A currently trades at $135.38 with a QOC of 9.5/10, while BDSX trades at $15.99 with a QOC of 6.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).